[68F1-68F1];[68F1-68F1];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
68F1;68F1
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3L)BSC395.
The presence of P+PBac{XP5.WH5}BSC574 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor insertion P{XP}d03723 to be Release 3 genomic coordinate 12039353 on chromosome arm 3L. The Gene Disruption project determined the insertion site of P{XP}d03723 to be Release 3 genomic coordinate 12039369 on arm 3L. This corresponds to 68F2 on the Release 3 and Release 5 genome maps. The predicted position of the progenitor insertion PBac{WH}CG6931f00440 on the Release 5 map is 68F1. Consequently, the cytological breakpoints of Df(3L)BSC574 are predicted to be 68F1;68F2.